Requadt Scott's Form 4 filing
Tourmaline Bio, Inc. (TRML) · filed Jul 28, 2022
- Accession no.
- 0000899243-22-026986
- Filed
- Jul 28, 2022
- Trade date
- Jul 26-28, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $36.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Requadt ScottCIK 0001664852 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 26, 2022 | Common Stock | PPurchaseAcquired | +5,528 | $4.24 | +$23,438.72 | 466,208 | Direct | |
| Jul 28, 2022 | Common Stock | PPurchaseAcquired | +3,090 | $4.25 | +$13,132.5 | 469,298 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.